David Rosenbaum - Feb 21, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Feb 21, 2023
Transactions value $
-$13,529
Form type
4
Date filed
2/24/2023, 04:36 PM
Previous filing
Jan 6, 2023
Next filing
Mar 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$10.2K -3.39K -0.9% $3.00 376K Feb 21, 2023 Direct F1
transaction ARDX Common Stock Sale -$3.34K -1.11K -0.98% $3.00 113K Feb 21, 2023 By Wife F1, F2
holding ARDX Common Stock 77.6K Feb 21, 2023 Family Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.